Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Rev Med Interne ; 37(3): 209-11, 2016 Mar.
Artículo en Francés | MEDLINE | ID: mdl-26320366

RESUMEN

INTRODUCTION: Hydroxychloroquine (HCQ) is most frequently used in the treatment of systemic inflammatory diseases. Cardiac complications of anti-malarial drugs are uncommon, and most of the time are the result of a long-term exposition. In this case, cardiotoxicity is the consequence of the lysosomal dysfunction and the result of intracytoplasmic granular material inclusions. CASE REPORT: We report a 77-year-old woman who presented a very early and reversible cardiotoxicity, probably related to the quinidine like effect of the HCQ, 10 days after initiation of therapy for Whipple endocarditis. CONCLUSION: We discuss the different mechanisms of cardiotoxicity of anti-malarial drugs and their clinical manifestations.


Asunto(s)
Antimaláricos/efectos adversos , Endocarditis Bacteriana/inducido químicamente , Hidroxicloroquina/efectos adversos , Anciano , Cardiotoxicidad , Endocarditis Bacteriana/patología , Femenino , Humanos , Enfermedad de Whipple/inducido químicamente , Enfermedad de Whipple/patología
3.
Pol Arch Med Wewn ; 108(3): 887-91, 2002 Sep.
Artículo en Polaco | MEDLINE | ID: mdl-12600186

RESUMEN

The case of 53-year-old man who suffered from chronic lymphocytic leukemia since 1993 was presented. In the 6th year of treatment fludarabine was administered. Few days after administration of drug the patient developed watery diarrhoea not responding to treatment. We excluded both infectious etiological factors and infiltration of intestine in course of chronic lymphocytic leukemia. Histopathological examination with monoclonal antibodies and periodic acid-Schiff stain (PAS) revealed Whipple's disease as the reason of enteropathy. During 6 months diarrhoea caused extreme dyselectrolitemia, renal insufficiency and finally death of the patient.


Asunto(s)
Antineoplásicos/efectos adversos , Inmunosupresores/efectos adversos , Leucemia Linfocítica Crónica de Células B/complicaciones , Leucemia Linfocítica Crónica de Células B/tratamiento farmacológico , Vidarabina/análogos & derivados , Vidarabina/efectos adversos , Enfermedad de Whipple/etiología , Antineoplásicos/administración & dosificación , Resultado Fatal , Humanos , Inmunosupresores/administración & dosificación , Leucemia Linfocítica Crónica de Células B/fisiopatología , Masculino , Persona de Mediana Edad , Factores de Tiempo , Vidarabina/administración & dosificación , Enfermedad de Whipple/inducido químicamente
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...